ADC Therapeutics (NYSE:ADCT) reported quarterly losses of $(0.73) per share which beat the analyst consensus estimate of $(0.91) by 19.78 percent. This is a 4.29 percent decrease over losses of $(0.70) per share from the same period last year.
Qualcomm Announces New Snapdragon Platforms, Bringing AI To PCs, Smartphones, Devices: ‘AI Will Play A Critical Role’
Technology company Qualcomm Inc (NASDAQ: QCOM) announced several new product launches and initiatives on Tuesday. Many of the new launches center on the company positioning itself to be a leader in artificial intelligence.
